Kura Oncology, Inc. (NASDAQ:KURA) Q3 2023 Earnings Call Transcript

Page 8 of 8

That’s what we’ve seen with every targeted therapy. There’s no reason to believe menin is any different. I think zifto has to stand pretty tall when you look at it that way.

Brad Canino: Appreciate it. Thanks, Troy.

Troy Wilson: Our pleasure. Thank you.

Operator: [Operator Instructions] There are no further questions at this time. Dr. Troy, please proceed with your closing remarks.

Troy Wilson: Thank you, Lester, and thank you all once again for joining our call today. We’ll be participating in the Stifel Healthcare Conference and the Jefferies London Healthcare Conference in a couple of weeks. We look forward to seeing many of you there. In the meantime, if you have any additional questions, please feel free to contact Pete, Tom or me. Thank you and have a good evening everyone.

Operator: Ladies and gentlemen, this concludes today’s conference. Thank you for participating. You may now disconnect.

Follow Kura Oncology Inc. (NASDAQ:KURA)

Page 8 of 8